Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Yi Chen

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialHenry L Y Chan, Scott Fung, Wai Kay Seto, et al.
Helicobacter|July 18, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisMei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 21, 2022
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis CChi-Yi Chen, Wan-Long Chuang, Albert Qin, et al.
Hepatology (Baltimore, Md.)|March 4, 2024
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patientsWon-Mook Choi, Terry Cheuk-Fung Yip, W Ray Kim, et al.
Journal of Hepatology|December 26, 2022
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysisWon-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Baseline Viral Load and On-Treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort StudyWon-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, et al.
Gastroenterology|November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2023
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trialsMei-Jyh Chen, Po-Yueh Chen, Yu-Jen Fang, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
The American Journal of Gastroenterology|February 3, 2016
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized TrialJyh-Ming Liou, Ming-Jong Bair, Chieh-Chang Chen, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialHenry L Y Chan, Scott Fung, Wai Kay Seto, et al.
Helicobacter|July 18, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisMei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 21, 2022
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis CChi-Yi Chen, Wan-Long Chuang, Albert Qin, et al.
Hepatology (Baltimore, Md.)|March 4, 2024
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patientsWon-Mook Choi, Terry Cheuk-Fung Yip, W Ray Kim, et al.
Journal of Hepatology|December 26, 2022
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysisWon-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Baseline Viral Load and On-Treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort StudyWon-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, et al.
Gastroenterology|November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2023
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trialsMei-Jyh Chen, Po-Yueh Chen, Yu-Jen Fang, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
The American Journal of Gastroenterology|February 3, 2016
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized TrialJyh-Ming Liou, Ming-Jong Bair, Chieh-Chang Chen, et al.
Pageof 14